|
Data variable
|
Description:
|
Coding:
|
Data Available
|
| Cancer Patient |
Divertic Patient |
Polyp Patient |
| StudyID |
Designates a specific specimen |
nnnnnnn - 7-digit ID |
X |
X |
X |
| TissueSource |
Identifies source (type) of tissue |
10=Colon Cancer
20=Normal tissue from diverticulitis patient
30=Normal tissue from cancer patient (matched)
40=Adenomatous colon polyp from patient with no evidence of cancer
|
X |
X |
X |
| Race |
Race of patient |
1=White
2=Black
3=American Indian
4=Asian
5=Pacific Islander
8=Other
9=Unknown
|
X |
X |
|
| Gender |
Gender of patient |
1=Male
2=Female
8=Other
9=Unknown
|
X |
X |
X |
| DxAge |
Age at diagnosis |
YYY |
X |
X |
X |
| DxYear |
Year of diagnosis |
YYYY |
X |
X |
X |
| NodesEx |
Nodes examined |
xx < 99 is Number of nodes examined
99=Unknown
|
X |
|
|
| NodesPos |
Nodes positive |
0=No nodes positive among those examined
0 < xx < 98 is Number of positive nodes
98=No nodes examined
99=Unknown
|
X |
|
|
| ProximalMarginInv |
Proximal margin involvement |
1=Cannot be assessed
2=Uninvolved by tumor
3=Involved by tumor
|
X |
|
|
| DistalMarginInv |
Distal margin involvement |
1=Cannot be assessed
2=Uninvolved by tumor
3=Involved by tumor
|
X |
|
|
| TStage |
AJCC (vers. 5) T stage |
1=TX Primary tumor cannot be assessed
2=T0 No evidence of primary tumor
3=Tis Carcinoma in situ
4=T1 Tumor invades sub mucosa
5=T2 Tumor invades muscularis propria
6=T3 Tumor invades thru muscularis propria into subserosa, nonperitonealized pericolic or perirectal tissue
7=T4 Tumor directly invades other organs, structures and/or perforates visceral peritoneum
|
X |
|
|
| NStage |
AJCC (vers. 5) N stage |
1=NX Regional lymph nodes cannot be assessed
2=N0 No regional lymph node metastasis
3=N1 Metastasis in one to three regional lymph nodes
4=N2 Metastasis in four or more regional lymph nodes
|
X |
|
|
| MStage |
AJCC (vers. 5) M stage |
1=MX Presence of distant metastasis cannot be assessed
2=M0 No distant metastasis
3=M1 Distant metastasis
|
X |
|
|
| SummaryStage |
AJCC (vers. 5) overall stage |
| Stage |
Dukes |
| 1=I |
T1 |
N0 |
M0 |
A |
| |
T2 |
N0 |
M0 |
A |
| 2=II |
T3 |
N0 |
M0 |
B |
| |
T4 |
N0 |
M0 |
B |
| 3=III |
Any T |
N1 |
M0 |
C |
| |
Any T |
N2 |
M0 |
C |
| 4=IV |
Any T |
Any N |
M1 |
C |
|
X |
|
|
| Histology |
Histology of tissue |
1=Adenocarcinoma
2=Mucinous adenocarcinoma (colloid type; > 50% mucinous adenocarcinoma)
3=Signet ring cell carcinoma (> 50% signet ring cell)
4=Medullary carcinoma
5=Undifferentiated carcinoma
6=Carcinoma, NOS
7=Other
|
X |
|
|
| HistologyGrade |
Histology grade of tissue |
1=GX Grade cannot be assessed
2=G1 Well differentiated
3=G2 Moderately differentiated
4=G3 Poorly differentiated
5=G4 Undifferentiated
NOTE:
G1 & G2 =low grade and G3 & G4=high grade
|
X |
|
|
| Location |
Location of cancer |
1=Right (ascending) colon
2=Hepatic flexure
3=Transverse colon
4=Splenic flexure
5=Left (descending) colon
6=Rectosigmoid junction
7=Cecum
8=Appendix
9=Sigmoid colon
10=Overlapping lesion
11=Colon, NOS
|
X |
|
|
| VascularInv |
Blood/lymphatic vessel invasion |
1=Intramural vessel
2=Extramural vessel
3=Absent
9=Cannot be assessed
|
X |
|
|
| VitalStatus |
Vital status at last follow-up |
1=Alive
2=Deceased |
X |
|
|
| TimeToDeath |
Time to death or length of time verified alive |
Months
Length of time (in months) from date of cancer diagnosis to death or last verified alive
|
X |
|
|
| Recurrence |
Did patient have a recurrence? |
0=No
1=Yes
If MStage=3, then Recurrence=0 and TimeToRecur=NA
|
X |
|
|
| TimeToRecur |
Time to recurrence or length of time verified recurrence free |
Months
Length of time (in months) from date of cancer diagnosis to first recurrence or last verified recurrence free
|
X |
|
|
| Typeoffirstrec |
Type of first recurrence |
0=None
10=Local
20=Regional
30=Any combination of 10 and 20
40=Distant
70=Never disease free
88=Recurred, but site unknown
|
X |
|
|
| LastFolup |
Cancer status at last follow-up |
1=Alive:No evidence of this cancer
2=Alive:Never free of this cancer
3=Alive:With persisting recurrence
5=Alive:Status of cancer unknown
6=Dead:No evidence of this ca at death
7=Dead:This ca present, not primary cause
8=Dead:This ca primary cause
10=Dead:Unknown if this ca the primary cause |
X |
|
|
| Chemotherapy |
Chemotherapy |
0=No 1=Yes |
X |
|
|
| RadiationTherapy |
Radiation therapy |
0=No 1=Yes |
X |
|
|
| Surgery |
Was patient treated with surgery? |
0=No 1=Yes |
X |
|
|
| SurgerytoChemo |
Time from surgery to chemotherapy |
Days from surgery to start of chemotherapy |
X |
|
|
| SurgerytoRadiation |
Time from surgery to radiation |
Days from surgery to start of radiation therapy |
X |
|
|
| Subgroup |
Recurrence subgroup |
a=Recurred <= 5 years after diagnosis
b=Followed and not recurred within 5 years of diagnosis
c=Not recurred but not followed a minimum of 5 years
|
X |
|
|
| AssociatedCancer Case |
Cancer case that this normal tissue is associated with |
Study ID of cancer case from which associated normal tissue was selected (applies only to normal tissue matched to cancer case) |
|
|
|
| Adenpolyp |
Type of adenomatous polyp |
1=Tubular adenoma
2=Tubulovillous adenoma
3=Villous adenoma
4=Other adenomatous polyp
5=Mixed hyperplastic and adenomatous |
|
|
X |
| Dysplasia |
Dysplasia of polyp |
1=High
2=Low
3=Absent |
|
|
X |
| Grosssize |
Gross size of largest polyp |
Greatest dimension in millimeters
99=size not determined
|
|
|
X |
| Comments |
Comments |
Text
Any special clinical, pathologic, or specimen information concerning this case that is not captured in the standard data fields
|
X |
X |
X |
